2026-01-09 – Press Releases – www.prnewswire.com
HONG KONG, Jan. 9, 2026 /PRNewswire/ — Ribo Life Science Co., Ltd. (“Ribo” or the “Company”, stock code: 06938.HK), a leading company in small interfering RNA (siRNA) therapeutics, today successfully listed on the Main Board of Hong Kong Stock Exchange, marking a significant milestone in…
